Renalytix AI, the developer of the KidneyIntelX kidney disease prognosis platform, is partnering with the American Diabetes Association to improve early diagnosis and treatment of kidney disease in people with type 2 diabetes.
Renalytix is focused on “bioprognosis” of kidney health. The company’s lead product, KidneyIntelX is an artificial intelligence platform for assessing chronic kidney disease (CKD) and quantifying CKD patients’ risk of...